Fresh Start Act of 2025

Natural Gas Tax Repeal ActThis bill eliminates a program administered by the Environmental Protection Agency that provides support for reducing methane emissions from the oil and gas sector. It also repeals a charge on methane emissions from facilities that contain petroleum and natural gas systems and emit 25,000 metric tons or more of greenhouse gases per year.

Emergency Care Improvement Act

SHIPS for America Act of 2025 Shipbuilding and Harbor Infrastructure for Prosperity and Security for America Act of 2025

To rename the Anahuac National Wildlife Refuge located in the State of Texas as the "Jocelyn Nungaray National Wildlife Refuge".

Border Safety and Security Act of 2025This bill requires the Department of Homeland Security (DHS) to suspend the entry of any non-U.S. nationals (aliens under federal law) without valid entry documents during any period when DHS cannot detain such an individual or return the individual to a foreign country contiguous to the United States. A state may sue DHS to enforce this requirement.(Under current law, non-U.S. nationals who arrive at the border without entry documents are generally subject to expedited removal. However, if such an individual is found to have a credible fear of persecution, they are typically subject to detention while their asylum claim is being considered.)The bill also authorizes DHS to suspend the entry of non-U.S. nationals without entry documents at the border if DHS determines that such a suspension is necessary to achieve operational control over such a border.

No Subsidies for Gender Transition Procedures Act

Valor Earned Not Stolen Act of 2025This bill increases the maximum prison term—from one year to three years—for an individual who falsely claims to be the recipient of certain military awards (e.g., a Medal of Honor or Purple Heart) with the intent to obtain money, property, or other tangible benefit.

Pregnancy.Gov Act

Organ Donation Referral Improvement Act

Conscience Protection Act of 2025

Title X Abortion Provider Prohibition ActThis bill prohibits the Department of Health and Human Services (HHS) from awarding family planning grants to entities that perform abortions or provide funding to other entities that perform abortions. To receive a grant, an entity must certify it will refrain from those activities during the grant period.The bill provides exceptions for abortions (1) in cases of rape or incest; or (2) when the life of the woman is in danger due to a physical disorder, injury, or illness. It also exempts hospitals unless they provide funds to non-hospital entities that provide abortions.HHS must submit a report to Congress annually on this prohibition.

Preserving Choice in Vehicle Purchases Act

Broadband Resiliency and Flexible Investment Act

The HCT/P Modernization Act of 2025This bill requires the Food and Drug Administration (FDA) to provide information to stakeholders and report on the regulation of human cell and tissue products, also referred to as human cells, tissues, or cellular or tissue-based products (HCT/Ps), which are articles containing or consisting of human cells or tissues that are intended for use in a human recipient.The bill requires the FDA to conduct workshops to educate stakeholders and facilitate discussion with them on advancing the science and regulation of human cell and tissue products. The FDA must establish a public docket to receive written comments on this topic, and submit to Congress a report with recommendations on regulating these products. Additionally, the bill requires the FDA to publish on its website educational materials about the Tissue Reference Group and best practices for obtaining a recommendation about products from them. Also, annually for three years, the FDA must publish on its website information on the inquiries submitted and average response times for the Tissue Reference Group, as well as the number of human cell and tissue manufacturers that have registered with the FDA and the number of inspections the FDA has conducted with respect to these manufacturers since 2019. (The Tissue Reference Group is a working group within the FDA that receives product-specific questions from, and provides recommendations for, stakeholders on the regulation of human cell and tissue products under the FDA’s rules.)